Company Filing History:
Years Active: 2011-2017
Title: Ivar Meyvantsson: Innovator in Microfluidics and Biopolymers
Introduction
Ivar Meyvantsson is a prominent inventor based in Madison, WI (US), known for his contributions to the fields of microfluidics and biopolymers. With a total of 8 patents, he has made significant advancements in methods for screening biologically active polypeptides and fluid pumping techniques in microfluidic devices.
Latest Patents
Meyvantsson's latest patents include a high throughput screen for biologically active polypeptides. This innovative method allows for the screening of libraries of polypeptides for biological activity on cells. The process involves synthesizing and encapsulating polypeptides along with their coding sequences in microcapsules of an emulsion. These emulsion microcapsules can then be fused with microcapsules containing test cells, enabling the assessment of biological activity on the cells to identify active polypeptides and their corresponding nucleic acid molecules.
Another notable patent is a method of pumping fluid through a microfluidic device. This method describes a technique for pumping fluid through a channel that has an input port and an output port. By generating a pressure gradient between the fluid at the input and output ports, fluid flows through the channel towards the output port, enhancing the efficiency of fluid movement in microfluidic applications.
Career Highlights
Throughout his career, Ivar Meyvantsson has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and Invenra Inc. His work has significantly impacted the development of innovative technologies in the life sciences and engineering sectors.
Collaborations
Meyvantsson has collaborated with notable colleagues, including David James Beebe and Michael W Toepke. These partnerships have fostered a collaborative environment that promotes innovation and the advancement of scientific knowledge.
Conclusion
Ivar Meyvantsson's contributions to the fields of microfluidics and biopolymers exemplify his dedication to innovation and research. His patents and collaborations continue to influence advancements in technology and science.